Delisted
Stopped trading. Last price we have: $15.50 on Feb 1, 2026. Fund positions aren't valued until we confirm what happened.

DYNAVAX TECHNOLOGIES CORP
DVAXHealthcare
DVAX (DYNAVAX TECHNOLOGIES CORP) is held by 0 institutional investors as of Q1 2026.
No verdict yet — fewer than 2 funds hold DVAX.
Top Holders
Fund ownership
Fund holdings as of
Funds holding0
Value of reported holdings$0
Funds buying / selling
Not available
Checking access…
Showing 1-20 of 143
1 / 8
| Insider | Trade | Traded |
|---|---|---|
| Novack David F | Sell $1.8M | |
| Novack David F | Exercise 94K sh | |
| Novack David F | Exercise 20K sh | |
| Spencer Ryan | Tax 138K sh | |
| MacDonald Kelly | Tax 36K sh | |
| Slebir John L | Tax 33K sh | |
| Novack David F | Sell $465K | |
| Novack David F | Exercise 10K sh | |
| Novack David F | Tax 48K sh | |
| Novack David F | Exercise 20K sh |
Loading Congress trades…
| Filer | Stake | Filed |
|---|---|---|
| Deep Track Capital, LP | 0.0% | |
| BlackRock, Inc. | 14.2% |
Continue exploring
Other Healthcare stocks held by institutions
456 holders · $264.6B
455 holders · $846.2B
442 holders · $208.3B
438 holders · $117B
437 holders · $430.7B
432 holders · $256.6B
425 holders · $314.1B
425 holders · $109.3B
418 holders · $123.6B
412 holders · $151.2B
Questions investors ask about DVAX
Who owns DVAX?
0 institutional investors held DVAX on March 31, 2026, according to their 13F filings.
How many hedge funds hold DVAX?
0 institutional investors reported DVAX in their 13F filings for the quarter ended March 31, 2026.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer